TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Fisher, interim NSABP Leadership Enter Third Day Of Negotiations To Settle Suit, Aver Court Battle September 30, 1994
TCL Archive In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril May 30, 1975